Workflow
Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings
CORCencora(COR) Benzinga·2025-05-07 18:06

Cencora, Inc COR on Wednesday reported second-quarter 2025 sales increased 10.3% to 75.5billion,missingthe consensusof75.5 billion, missing the consensus of 75.68 billion, primarily due to an 11.4% increase in revenue within the U.S. Healthcare Solutions segment.U.S. Healthcare Solutions revenue was $68.3 billion, due to overall market growth primarily driven by unit volume growth, including increased sales of products labeled for diabetes and/or weight loss in the GLP-1 class and specialty products to physician practices and health syste ...